English

SomaLogic, Inc.

EDGAR

CMII Current report (8-K) · filed 2024-01-02

18 filing records in this dataset, filed from 2021-02-01 to 2024-01-02. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

22 million USD

2023 Q3 · USD

Exact inputs and evidence

Revenue: 22048000 USD Source

Operating margin

-127.37%

2023 Q3 · %

Exact inputs and evidence

Operating Income: -28082000 USD Source
Revenue: 22048000 USD Source

Operating cash flow

-21.4 million USD

2023 Q3 · USD

Exact inputs and evidence

Operating Cash Flow: -90647000 USD Source
Operating Cash Flow: -69282000 USD Source

Free cash flow

-21.7 million USD

2023 Q3 · USD

Exact inputs and evidence

Operating Cash Flow: -90647000 USD Source
Operating Cash Flow: -69282000 USD Source
Capital Expenditure: 2519000 USD Source
Capital Expenditure: 2148000 USD Source

Cash and cash equivalents: 306 million USD 2023-09-30 Source
Exact value

305571000 USD
Long-term debt including current maturities: 0 USD 2021-12-31 Source
Exact value

0 USD
Shares outstanding: 189 million shares 2023-09-30 Source
Exact value

188662349 shares

Reported share-count change

0.62% · 1.17 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

187495940 shares · 2022-09-30· Source
188662349 shares · 2023-09-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

81.7 million USD

2022-10-01 – 2023-09-30

Exact inputs and evidence

Revenue: 97666000 USD · 2022-01-01 – 2022-12-31 Source
Revenue: 78837000 USD · 2022-01-01 – 2022-09-30 Source
Revenue: 20379000 USD · 2023-01-01 – 2023-03-31 Source
Revenue: 20468000 USD · 2023-04-01 – 2023-06-30 Source
Revenue: 22048000 USD · 2023-07-01 – 2023-09-30 Source

Net income

-130 million USD

2022-10-01 – 2023-09-30

Exact inputs and evidence

Net income: -109157000 USD · 2022-01-01 – 2022-12-31 Source
Net income: -59906000 USD · 2022-01-01 – 2022-09-30 Source
Net income: -34202000 USD · 2023-01-01 – 2023-03-31 Source
Net income: -24772000 USD · 2023-04-01 – 2023-06-30 Source
Net income: -22157000 USD · 2023-07-01 – 2023-09-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2024-01-02.

Financial data available through: 2022-12-31.

Coverage by financial measure

Revenue: 3 of 11 periods available· newest 2022-12-31
Operating income: 3 of 11 periods available· newest 2022-12-31
Net income: 3 of 11 periods available· newest 2022-12-31
Operating cash flow: 3 of 11 periods available· newest 2022-12-31
Capital expenditure: 3 of 11 periods available· newest 2022-12-31
Total assets: 3 of 11 periods available· newest 2022-12-31
Total liabilities: 3 of 11 periods available· newest 2022-12-31
Current assets: 3 of 11 periods available· newest 2022-12-31
Current liabilities: 3 of 11 periods available· newest 2022-12-31
Cash and cash equivalents: 3 of 11 periods available· newest 2022-12-31
Long-term debt including current maturities: 2 of 11 periods available· newest 2021-12-31
Shares outstanding: 3 of 11 periods available· newest 2022-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+19.7%

Prior period

USD 81.63 million

2021-01-01 – 2021-12-31
Current period

USD 97.67 million

2022-01-01 – 2022-12-31

Exact inputs and evidence

97666000 − 81626000 = 16040000 USD

81626000 USD · 2021-01-01 – 2021-12-31
Inspect prior input Prior source
97666000 USD · 2022-01-01 – 2022-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · SomaLogic, Inc. · 2022-12-31 SomaLogic, Inc. (edgar:1837412) Year-over-year change in Revenue: 16040000 USD Concept: fundies:Revenue Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T07:42:47Z Snapshot: b00c7cb6f202877c9593a1b6336c9e649ffaec2b62bc31f9f9381c6201bd293c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1837412?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 97666000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1837412/000162828023009564/slgc-20221231.htm#1382749 Filing: 000162828023009564 Input fundies:Revenue: 81626000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1837412/000162828023009564/slgc-20221231.htm#1383725 Filing: 000162828023009564
The citation records this snapshot. The page link may show a newer release later.
Net income
−USD 21.61 million

Prior period

−USD 87.55 million

2021-01-01 – 2021-12-31
Current period

−USD 109.16 million

2022-01-01 – 2022-12-31

Exact inputs and evidence

-109157000 − -87547000 = -21610000 USD

-87547000 USD · 2021-01-01 – 2021-12-31
Inspect prior input Prior source
-109157000 USD · 2022-01-01 – 2022-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · SomaLogic, Inc. · 2022-12-31 SomaLogic, Inc. (edgar:1837412) Year-over-year change in Net income: -21610000 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T07:42:47Z Snapshot: b00c7cb6f202877c9593a1b6336c9e649ffaec2b62bc31f9f9381c6201bd293c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1837412?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -109157000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1837412/000162828023009564/slgc-20221231.htm#1817327 Filing: 000162828023009564 Input fundies:NetIncome: -87547000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1837412/000162828023009564/slgc-20221231.htm#1818225 Filing: 000162828023009564
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 60.29 million

Prior period

−USD 40.38 million

2021-01-01 – 2021-12-31
Current period

−USD 100.67 million

2022-01-01 – 2022-12-31

Exact inputs and evidence

-100669000 − -40384000 = -60285000 USD

-40384000 USD · 2021-01-01 – 2021-12-31
Inspect prior input Prior source
-100669000 USD · 2022-01-01 – 2022-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · SomaLogic, Inc. · 2022-12-31 SomaLogic, Inc. (edgar:1837412) Year-over-year change in Operating cash flow: -60285000 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T07:42:47Z Snapshot: b00c7cb6f202877c9593a1b6336c9e649ffaec2b62bc31f9f9381c6201bd293c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1837412?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -100669000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1837412/000162828023009564/slgc-20221231.htm#1061687 Filing: 000162828023009564 Input fundies:OperatingCashFlow: -40384000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1837412/000162828023009564/slgc-20221231.htm#1141600 Filing: 000162828023009564
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+57.7%

Prior period

USD 3.31 million

2021-01-01 – 2021-12-31
Current period

USD 5.22 million

2022-01-01 – 2022-12-31

Exact inputs and evidence

5215000 − 3307000 = 1908000 USD

3307000 USD · 2021-01-01 – 2021-12-31
Inspect prior input Prior source
5215000 USD · 2022-01-01 – 2022-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · SomaLogic, Inc. · 2022-12-31 SomaLogic, Inc. (edgar:1837412) Year-over-year change in Capital expenditure: 1908000 USD Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T07:42:47Z Snapshot: b00c7cb6f202877c9593a1b6336c9e649ffaec2b62bc31f9f9381c6201bd293c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1837412?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 5215000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1837412/000162828023009564/slgc-20221231.htm#1066380 Filing: 000162828023009564 Input fundies:CapitalExpenditure: 3307000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1837412/000162828023009564/slgc-20221231.htm#1144905 Filing: 000162828023009564
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2022 2022-01-01 – 2022-12-31

Revenue USD 97.67 million 100% of revenue
Operating costs Derived USD 273.43 million 280% of revenue
Operating income −USD 175.76 million −180% of revenue
Tax, interest and other Derived −USD 66.6 million −68% of revenue
Net income −USD 109.16 million −112% of revenue

Cash

Operating cash flow −USD 100.67 million −103% of revenue
Capital expenditure USD 5.22 million 5.3% of revenue
Free cash flow Derived −USD 105.88 million −108% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2020 Operating loss: operating costs were 161% of revenue.
2021 Operating loss: operating costs were 190% of revenue.
2022 Operating loss: operating costs were 280% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2020 2020-01-01 – 2020-12-31	55889000	90245000 Derived	-34356000	18659000 Derived	-53015000	-29495000 Derived	Source 2020-01-01 – 2020-12-31: 55889000 USD Inspect Revenue Open source 2020-01-01 – 2020-12-31: -34356000 USD Inspect Operating Income Open source 2020-01-01 – 2020-12-31: -53015000 USD Inspect Net Income Open source 2020-01-01 – 2020-12-31: -28338000 USD Inspect Operating Cash Flow Open source 2020-01-01 – 2020-12-31: 1157000 USD Inspect Capital Expenditure Open source
2021 2021-01-01 – 2021-12-31	81626000	154930000 Derived	-73304000	14243000 Derived	-87547000	-43691000 Derived	Source 2021-01-01 – 2021-12-31: 81626000 USD Inspect Revenue Open source 2021-01-01 – 2021-12-31: -73304000 USD Inspect Operating Income Open source 2021-01-01 – 2021-12-31: -87547000 USD Inspect Net Income Open source 2021-01-01 – 2021-12-31: -40384000 USD Inspect Operating Cash Flow Open source 2021-01-01 – 2021-12-31: 3307000 USD Inspect Capital Expenditure Open source
2022 2022-01-01 – 2022-12-31	97666000	273427000 Derived	-175761000	-66604000 Derived	-109157000	-105884000 Derived	Source 2022-01-01 – 2022-12-31: 97666000 USD Inspect Revenue Open source 2022-01-01 – 2022-12-31: -175761000 USD Inspect Operating Income Open source 2022-01-01 – 2022-12-31: -109157000 USD Inspect Net Income Open source 2022-01-01 – 2022-12-31: -100669000 USD Inspect Operating Cash Flow Open source 2022-01-01 – 2022-12-31: 5215000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 97.7M 2022

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20202020-12-31	Revenue	55889000	Revenue: 55889000 Open source
20212021-12-31	Revenue	81626000	Revenue: 81626000 Open source
20222022-12-31	Revenue	97666000	Revenue: 97666000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

19.7% 2022

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20202020-12-31	Year over year	No prior comparable period	Revenue: 55889000 Open source
20212021-12-31	Year over year	46.1%	Revenue: 81626000 Open source Revenue: 55889000 Open source
20222022-12-31	Year over year	19.7%	Revenue: 97666000 Open source Revenue: 81626000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -180% 2022

Net margin -111.8% 2022

Free cash flow margin -108.4% 2022

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20202020-12-31	Operating margin	-61.5%	Operating Income: -34356000 Open source Revenue: 55889000 Open source
20212021-12-31	Operating margin	-89.8%	Operating Income: -73304000 Open source Revenue: 81626000 Open source
20222022-12-31	Operating margin	-180%	Operating Income: -175761000 Open source Revenue: 97666000 Open source
20202020-12-31	Net margin	-94.9%	Net Income: -53015000 Open source Revenue: 55889000 Open source
20212021-12-31	Net margin	-107.3%	Net Income: -87547000 Open source Revenue: 81626000 Open source
20222022-12-31	Net margin	-111.8%	Net Income: -109157000 Open source Revenue: 97666000 Open source
20202020-12-31	Free cash flow margin	-52.8%	Revenue: 55889000 Open source Operating Cash Flow: -28338000 Open source Capital Expenditure: 1157000 Open source
20212021-12-31	Free cash flow margin	-53.5%	Revenue: 81626000 Open source Operating Cash Flow: -40384000 Open source Capital Expenditure: 3307000 Open source
20222022-12-31	Free cash flow margin	-108.4%	Revenue: 97666000 Open source Operating Cash Flow: -100669000 Open source Capital Expenditure: 5215000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -100.7M 2022

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20202020-12-31	Operating cash flow	-28338000	Operating Cash Flow: -28338000 Open source
20212021-12-31	Operating cash flow	-40384000	Operating Cash Flow: -40384000 Open source
20222022-12-31	Operating cash flow	-100669000	Operating Cash Flow: -100669000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -105.9M 2022

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20202020-12-31	Free cash flow	-29495000	Operating Cash Flow: -28338000 Open source Capital Expenditure: 1157000 Open source
20212021-12-31	Free cash flow	-43691000	Operating Cash Flow: -40384000 Open source Capital Expenditure: 3307000 Open source
20222022-12-31	Free cash flow	-105884000	Operating Cash Flow: -100669000 Open source Capital Expenditure: 5215000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

13.1% 2022

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20202020-12-31	Liabilities / assets	23.3%	Total Liabilities: 56373000 Open source Total Assets: 242290000 Open source
20212021-12-31	Liabilities / assets	13.3%	Total Liabilities: 94078000 Open source Total Assets: 706102000 Open source
20222022-12-31	Liabilities / assets	13.1%	Total Liabilities: 84816000 Open source Total Assets: 647374000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

13.42× 2022

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20202020-12-31	Current assets / current liabilities	13.03×	Current Assets: 231975000 Open source Current Liabilities: 17797000 Open source
20212021-12-31	Current assets / current liabilities	23.61×	Current Assets: 691552000 Open source Current Liabilities: 29285000 Open source
20222022-12-31	Current assets / current liabilities	13.42×	Current Assets: 581701000 Open source Current Liabilities: 43332000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2020 2020-01-01 – 2020-12-31	−USD 53.02 million Exact value Exact value: -53015000 USD 2020-01-01 – 2020-12-31: -53015000 USD Inspect Net Income Open source Share or cite Citation for Net Income · SomaLogic, Inc. · 2020-12-31 SomaLogic, Inc. (edgar:1837412) Net Income: -53015000 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T07:42:47Z Snapshot: b00c7cb6f202877c9593a1b6336c9e649ffaec2b62bc31f9f9381c6201bd293c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1837412/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: -53015000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1837412/000162828022007711/slgc-20211231.htm#2160539 Filing: 000162828022007711 The citation records this snapshot. The page link may show a newer release later.	−USD 28.34 million Exact value Exact value: -28338000 USD 2020-01-01 – 2020-12-31: -28338000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SomaLogic, Inc. · 2020-12-31 SomaLogic, Inc. (edgar:1837412) Operating Cash Flow: -28338000 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T07:42:47Z Snapshot: b00c7cb6f202877c9593a1b6336c9e649ffaec2b62bc31f9f9381c6201bd293c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1837412/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -28338000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1837412/000162828022007711/slgc-20211231.htm#1296160 Filing: 000162828022007711 The citation records this snapshot. The page link may show a newer release later.	USD 1.16 million Exact value Exact value: 1157000 USD 2020-01-01 – 2020-12-31: 1157000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SomaLogic, Inc. · 2020-12-31 SomaLogic, Inc. (edgar:1837412) Capital Expenditure: 1157000 USD Concept: fundies:CapitalExpenditure Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T07:42:47Z Snapshot: b00c7cb6f202877c9593a1b6336c9e649ffaec2b62bc31f9f9381c6201bd293c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1837412/explain?concept=fundies%3ACapitalExpenditure&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1157000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1837412/000162828022007711/slgc-20211231.htm#1300976 Filing: 000162828022007711 The citation records this snapshot. The page link may show a newer release later.	−USD 29.5 million Calculation and evidence -28338000 − 1157000 USD Exact free cash flow: -29495000 USD 2020-01-01 – 2020-12-31: -28338000 USD · Inspect Operating Cash Flow · Source 2020-01-01 – 2020-12-31: 1157000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SomaLogic, Inc. · 2020-12-31 SomaLogic, Inc. (edgar:1837412) Free cash flow: -29495000 USD Concept: free-cash-flow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T07:42:47Z Snapshot: b00c7cb6f202877c9593a1b6336c9e649ffaec2b62bc31f9f9381c6201bd293c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1837412?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -28338000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1837412/000162828022007711/slgc-20211231.htm#1296160 Filing: 000162828022007711 Input fundies:CapitalExpenditure: 1157000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1837412/000162828022007711/slgc-20211231.htm#1300976 Filing: 000162828022007711 The citation records this snapshot. The page link may show a newer release later.
2021 2021-01-01 – 2021-12-31	−USD 87.55 million Exact value Exact value: -87547000 USD 2021-01-01 – 2021-12-31: -87547000 USD Inspect Net Income Open source Share or cite Citation for Net Income · SomaLogic, Inc. · 2021-12-31 SomaLogic, Inc. (edgar:1837412) Net Income: -87547000 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T07:42:47Z Snapshot: b00c7cb6f202877c9593a1b6336c9e649ffaec2b62bc31f9f9381c6201bd293c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1837412/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: -87547000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1837412/000162828023009564/slgc-20221231.htm#1818225 Filing: 000162828023009564 The citation records this snapshot. The page link may show a newer release later.	−USD 40.38 million Exact value Exact value: -40384000 USD 2021-01-01 – 2021-12-31: -40384000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SomaLogic, Inc. · 2021-12-31 SomaLogic, Inc. (edgar:1837412) Operating Cash Flow: -40384000 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T07:42:47Z Snapshot: b00c7cb6f202877c9593a1b6336c9e649ffaec2b62bc31f9f9381c6201bd293c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1837412/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -40384000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1837412/000162828023009564/slgc-20221231.htm#1141600 Filing: 000162828023009564 The citation records this snapshot. The page link may show a newer release later.	USD 3.31 million Exact value Exact value: 3307000 USD 2021-01-01 – 2021-12-31: 3307000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SomaLogic, Inc. · 2021-12-31 SomaLogic, Inc. (edgar:1837412) Capital Expenditure: 3307000 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T07:42:47Z Snapshot: b00c7cb6f202877c9593a1b6336c9e649ffaec2b62bc31f9f9381c6201bd293c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1837412/explain?concept=fundies%3ACapitalExpenditure&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 3307000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1837412/000162828023009564/slgc-20221231.htm#1144905 Filing: 000162828023009564 The citation records this snapshot. The page link may show a newer release later.	−USD 43.69 million Calculation and evidence -40384000 − 3307000 USD Exact free cash flow: -43691000 USD 2021-01-01 – 2021-12-31: -40384000 USD · Inspect Operating Cash Flow · Source 2021-01-01 – 2021-12-31: 3307000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SomaLogic, Inc. · 2021-12-31 SomaLogic, Inc. (edgar:1837412) Free cash flow: -43691000 USD Concept: free-cash-flow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T07:42:47Z Snapshot: b00c7cb6f202877c9593a1b6336c9e649ffaec2b62bc31f9f9381c6201bd293c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1837412?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -40384000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1837412/000162828023009564/slgc-20221231.htm#1141600 Filing: 000162828023009564 Input fundies:CapitalExpenditure: 3307000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1837412/000162828023009564/slgc-20221231.htm#1144905 Filing: 000162828023009564 The citation records this snapshot. The page link may show a newer release later.
2022 2022-01-01 – 2022-12-31	−USD 109.16 million Exact value Exact value: -109157000 USD 2022-01-01 – 2022-12-31: -109157000 USD Inspect Net Income Open source Share or cite Citation for Net Income · SomaLogic, Inc. · 2022-12-31 SomaLogic, Inc. (edgar:1837412) Net Income: -109157000 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T07:42:47Z Snapshot: b00c7cb6f202877c9593a1b6336c9e649ffaec2b62bc31f9f9381c6201bd293c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1837412/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:NetIncome: -109157000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1837412/000162828023009564/slgc-20221231.htm#1817327 Filing: 000162828023009564 The citation records this snapshot. The page link may show a newer release later.	−USD 100.67 million Exact value Exact value: -100669000 USD 2022-01-01 – 2022-12-31: -100669000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SomaLogic, Inc. · 2022-12-31 SomaLogic, Inc. (edgar:1837412) Operating Cash Flow: -100669000 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T07:42:47Z Snapshot: b00c7cb6f202877c9593a1b6336c9e649ffaec2b62bc31f9f9381c6201bd293c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1837412/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -100669000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1837412/000162828023009564/slgc-20221231.htm#1061687 Filing: 000162828023009564 The citation records this snapshot. The page link may show a newer release later.	USD 5.22 million Exact value Exact value: 5215000 USD 2022-01-01 – 2022-12-31: 5215000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SomaLogic, Inc. · 2022-12-31 SomaLogic, Inc. (edgar:1837412) Capital Expenditure: 5215000 USD Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T07:42:47Z Snapshot: b00c7cb6f202877c9593a1b6336c9e649ffaec2b62bc31f9f9381c6201bd293c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1837412/explain?concept=fundies%3ACapitalExpenditure&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 5215000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1837412/000162828023009564/slgc-20221231.htm#1066380 Filing: 000162828023009564 The citation records this snapshot. The page link may show a newer release later.	−USD 105.88 million Calculation and evidence -100669000 − 5215000 USD Exact free cash flow: -105884000 USD 2022-01-01 – 2022-12-31: -100669000 USD · Inspect Operating Cash Flow · Source 2022-01-01 – 2022-12-31: 5215000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SomaLogic, Inc. · 2022-12-31 SomaLogic, Inc. (edgar:1837412) Free cash flow: -105884000 USD Concept: free-cash-flow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T07:42:47Z Snapshot: b00c7cb6f202877c9593a1b6336c9e649ffaec2b62bc31f9f9381c6201bd293c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1837412?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -100669000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1837412/000162828023009564/slgc-20221231.htm#1061687 Filing: 000162828023009564 Input fundies:CapitalExpenditure: 5215000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1837412/000162828023009564/slgc-20221231.htm#1066380 Filing: 000162828023009564 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

18 filings · 929 latest values · 927 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001837412, 1837412, CMII, edgar:1837412

Also known as CM LIFE SCIENCES II INC., CM Life Sciences II Inc., SOMALOGIC, INC., SomaLogic, Inc.

SomaLogic, Inc.

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Reported share-count change

Trailing twelve months

Revenue

Net income

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2022 2022-01-01 – 2022-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation